Filter by Industry
Filter by Topic
Rare Disease Day 2026: Rounding up the latest advancements in research and treatment
Keep up with the latest in rare disease news. Our roundup highlights important research and technological advancements that impact rare disease…
How the Healthcare Cybersecurity Act could impact the healthcare landscape
Learn what the Healthcare Cybersecurity Act could mean for providers, vendors, and healthcare cybersecurity workforce development.
GLP-1 coverage cuts: What shifting payer policies mean for prescribing, access, and utilization
As insurers cut GLP‑1 coverage for weight loss, claims data could reveal shifts in prescribing, access, and utilization.
With federal healthcare cuts looming, how can providers better target commercially insured patients?
Learn how health systems can better identify and target commercially insured patients as Medicare reimbursement declines.
Reach at-risk CVD patients earlier with digital audiences
This American Heart Month, we discuss the importance of identifying and engaging people at risk of CVD faster and earlier in the patient journey.
Expiration of enhanced ACA subsidies: What it means for providers—and how to respond
Learn how the expiration of enhanced ACA subsidies affects provider volume, payer mix, and revenue, and how data-driven forecasting can help providers…
What are some of the most common rare diseases?
Explore the most common rare diseases in the U.S., based on real-world claims data, and see how prevalence varies by geography.
4 overlooked growth opportunities in cardiovascular care
This American Heart Month, explore how MedTech can identify untreated cardiovascular patients to improve patient outcomes.
Phase-out of the CMS IPO list: What it means for site-of-care shifts, volumes, and revenue mix
Learn how the CMS IPO List phase-out will shift procedures to ASCs and outpatient settings—and what it means for volume, revenue mix, and strategy.
What the CDC’s updated vaccine schedule means for providers, insurers, and drugmakers
Explore how evolving CDC and ACIP vaccine recommendations are reshaping vaccination volume, claims patterns, and demand forecasting.